IAS-USA Dialogue Series: Emerging Infections and Health Threats
IAS–USA Dialogues are spirited, timely conversations on the public health, scientific, and clinical aspects of current urgent outbreaks, including seasonal viruses such as influenza, emerging infectious disease threats in the US and around the world, controversies surrounding trustworthy guidance on vaccinations, and other topics of the day. Registration is now open for our (more…)
Chlamydia Management Updates: Advances and Vaccine Development for STI Prevention
Overview Assessment of Needs Rapid advances in sexually transmitted infection (STI) and HIV disease management require the ongoing attention of practitioners involved in direct patient care. Chlamydia trachomatis is the most commonly reported STI. This webinar will outline current chlamydia treatment recommendations, describe the pipeline for STI vaccine trials and review current clinical (more…)
The 2025 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
The 2025 RWHAP CLINICAL CONFERENCE will be in-person only. There will not be a virtual component. This conference is specifically for clinical decision makers (MD/DOs, PAs, and NPs) in RWHAP-funded programs or clinics. A limited number of registration spots are available for registered (more…)
No Mo’ FOMO 2026: In Case You Missed It—Recent Changes in Guidelines, New Publications, and Updates From Recent Conferences
Overview Assessment of Needs The management and treatment of patients with HIV constantly evolve as new data are presented at conferences and published in scholarly journals. This webinar summarizes current and new data on the HIV epidemic, including data from recent clinical trials and updates from recent conferences. Topics include the prevention and (more…)
Drug-Drug Interactions, Dosing, Formulations, and Other Pharmacologic Issues in HIV Treatment
Overview Assessment of Needs Clinicians managing patients with HIV require updated education on pharmacologic considerations that impact treatment safety and efficacy. There is a clear need for enhanced understanding of drug-drug interactions, metabolic and clearance pathways, and the interpretation of laboratory results affected by specific antiretroviral agents. Additionally, practitioners must be aware of (more…)
Managing ART Options in the Setting of HIV Drug Resistance
Overview Assessment of Needs Although the overall incidence of HIV drug resistance has declined in the era of modern antiretroviral therapy (ART), some individuals continue to experience treatment failure due to the emergence of drug resistance. These patients require innovative and effective therapeutic strategies to achieve and maintain viral suppression. This webinar will (more…)